Pharmaceutical, biotech, and life science companies operating in the UK and EU are required to maintain robust quality systems and ensure regulatory compliance. GMP (Good Manufacturing Practice), GDP (Good Distribution Practice), and GVP (Good Pharmacovigilance Practice) audits are critical for maintaining oversight of internal processes, suppliers, and outsourced vendors.
One of the most common questions companies face is: “Should we rely on internal audits, external audits, or both?” Understanding the differences, benefits, and expectations of MHRA and EMA regulators can help organisations plan an effective audit strategy.
What Are Internal Audits?
Internal audits are conducted by a company’s own quality team or trained staff. They assess compliance with internal policies, SOPs, and regulatory requirements. Internal audits are typically scheduled as part of a risk-based audit plan and provide continuous monitoring of processes.
Key benefits of internal audits:
- Identify compliance gaps before regulators do
- Ensure SOPs and processes are being followed consistently
- Support staff training and competency assessments
- Facilitate ongoing CAPA verification
- Provide a documented record of proactive quality management
Example: A UK pharmaceutical manufacturer may conduct an internal GMP audit of its production line to check adherence to SOPs, training compliance, and equipment calibration schedules.
What Are External Audits?
External audits are conducted by third-party experts, consultants, or regulatory inspectors. They provide independent evaluation of processes and systems, often offering a fresh perspective on compliance risks. External audits can cover:
- Internal processes (GMP, GDP, or GVP)
- Supplier or vendor activities
- Pharmacovigilance systems and third-party service providers
Key benefits of external audits:
- Provide objective assessment of your quality systems
- Highlight areas of risk that internal teams may overlook
- Support regulatory inspection readiness
- Offer actionable recommendations for CAPA and remediation
- Increase confidence with regulators during MHRA or EMA inspections
Example: A CRO providing pharmacovigilance services may undergo an external GVP audit to demonstrate compliance to a sponsor company before submitting data to the MHRA.
Key Differences Between Internal and External Audits
- Who conducts them:
- Internal audits are carried out by your company’s own trained staff or quality team.
- External audits are conducted by independent consultants, auditors, or regulatory bodies.
- Purpose:
- Internal audits focus on continuous monitoring, gap identification, and staff development.
- External audits provide independent verification, regulatory confidence, and risk assessment.
- Frequency:
- Internal audits are regular, often scheduled quarterly, bi-annually, or annually based on risk.
- External audits are scheduled or on-demand, often for high-risk areas or to prepare for inspections.
- Scope:
- Internal audits primarily assess company processes and procedures.
- External audits evaluate processes, vendor compliance, and regulatory adherence across the supply chain.
- Value:
- Internal audits allow early detection of issues and are cost-effective.
- External audits provide a fresh perspective, objective reporting, and support for inspection readiness.
Why Both Are Critical for MHRA and EMA Compliance
Regulators expect companies to maintain robust, risk-based audit programs that combine both internal and external audits. Internal audits demonstrate continuous oversight, while external audits provide independent evidence of compliance and readiness. Together, they create a comprehensive quality oversight system.
Key considerations for UK companies:
- Schedule internal audits early in the year to review processes, CAPAs, and SOPs.
- Use external audits for high-risk areas such as CMOs, PV vendors, or critical suppliers.
- Document all audits thoroughly to demonstrate continuous monitoring during MHRA inspections.
- Integrate findings from both audit types into your annual CAPA and quality improvement plan.
Common Mistakes Companies Make
Despite best intentions, many organisations:
- Rely solely on internal audits and lack independent verification
- Conduct external audits infrequently or only reactively
- Fail to document audit results and CAPA follow-ups
- Neglect training staff on audit preparedness or inspector interactions
Avoiding these mistakes strengthens compliance and improves outcomes during inspections.
Tips for Effective Audit Planning
- Use a risk-based approach: Prioritise audits based on critical processes, past findings, and regulatory requirements.
- Combine internal and external audits: Internal audits maintain oversight; external audits provide objective assessment.
- Align audits with inspection readiness: Schedule audits to support MHRA or EMA inspection preparation.
- Integrate CAPA management: Ensure audit findings feed into CAPA plans and track closure.
- Engage independent experts when needed: Smaller organisations can benefit from external guidance on high-risk areas.
Strengthening Your Quality Oversight Program
A robust audit strategy that balances internal and external audits ensures compliance, improves process efficiency, and demonstrates a culture of quality. It also strengthens confidence with regulators during inspections and reduces the risk of findings related to GMP, GDP, or GVP.
By proactively planning your audits and using a risk-based approach, UK pharmaceutical companies can identify gaps early, maintain operational excellence, and be inspection-ready year-round.
📞 Need Support with Internal and External Audits?
Quality Vigilance provides GMP, GDP, and GVP audit services, inspection readiness support, CAPA management, and independent quality oversight for pharmaceutical, biotech, and life science companies across the UK and EU.
📩 Email: [email protected]
🌐 Website: www.qualityvigilance.com
📞 Phone: +44 7474 964491
Contact us today to discuss how we can help your company plan and execute effective internal and external audits to stay fully compliant and inspection-ready.